Magnetic labeling of activated microglia in experimental gliomas

被引:104
作者
Fleige, G
Nolte, C
Synowitz, M
Seeberger, F
Kettenmann, H
Zimmer, C
机构
[1] Humboldt Univ, Charite Med Sch, Dept Radiol, D-10117 Berlin, Germany
[2] Humboldt Univ, Charite Med Sch, Dept Neuroradiol, D-10117 Berlin, Germany
[3] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany
来源
NEOPLASIA | 2001年 / 3卷 / 06期
关键词
microglia; MRI; glioma; magnetic cell labeling; superparamagnetic iron oxides (USPIO);
D O I
10.1038/sj.neo.7900176
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Microglia, as intrinsic immunoeffector cells of the central nervous system (CNS), play a very sensitive, crucial role in the response to almost any brain pathology where they are activated to a phagocytic state. Based on the characteristic features of activated microglia, we investigated whether these cells can be visualized with magnetic resonance imaging (MRI) using ultrasmall superparamagnetic iron oxides (USPIOs). The hypothesis of this study was that MR microglia visualization could not only reveal the extent of the tumor, but also allow for assessing the status of immunologic defense. Using USPIOs in cell culture experiments and in a rat glioma model, we showed that microglia can be labeled magnetically. Labeled microglia are detected by confocal microscopy within and around tumors in a typical border-like pattern. Quantitative in vitro studies revealed that microglia internalize amounts of USPIOs that are significantly higher than those incorporated by tumor cells and astrocytes. Labeled microglia can be detected and quantified with MRI in cell phantoms, and the extent of the tumor can be seen in glioma-bearing rats in vivo. We conclude that magnetic labeling of microglia provides a potential tool for MRI of gliomas, which reflects tumor morphology precisely. Furthermore, the results suggest that MRI may yield functional data on the immunologic reaction of the CNS.
引用
收藏
页码:489 / 499
页数:11
相关论文
共 62 条
[1]
In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor scatter factor [J].
Badie, B ;
Schartner, J ;
Klaver, J ;
Vorpahl, J .
NEUROSURGERY, 1999, 44 (05) :1077-1082
[2]
Flow cytometric characterization of tumor-associated macrophages in experimental gliomas [J].
Badie, B ;
Schartner, JM .
NEUROSURGERY, 2000, 46 (04) :957-961
[3]
The peripheral benzodiazepine binding site in the brain in multiple sclerosis -: Quantitative in vivo imaging of microglia as a measure of disease activity [J].
Banati, RB ;
Newcombe, J ;
Gunn, RN ;
Cagnin, A ;
Turkheimer, F ;
Heppner, F ;
Price, G ;
Wegner, F ;
Giovannoni, G ;
Miller, DH ;
Perkin, GD ;
Smith, T ;
Hewson, AK ;
Bydder, G ;
Kreutzberg, GW ;
Jones, T ;
Cuzner, ML ;
Myers, R .
BRAIN, 2000, 123 :2321-2337
[5]
Magnetic resonance microscopy of the C57BL mouse brain [J].
Benveniste, H ;
Kim, K ;
Zhang, L ;
Johnson, GA .
NEUROIMAGE, 2000, 11 (06) :601-611
[6]
Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy [J].
Benveniste, H ;
Einstein, G ;
Kim, KR ;
Hulette, C ;
Johnson, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) :14079-14084
[7]
The development of in vivo imaging systems to study gene expression [J].
Bogdanov, A ;
Weissleder, R .
TRENDS IN BIOTECHNOLOGY, 1998, 16 (01) :5-10
[8]
Brockhaus J, 1996, GLIA, V16, P81, DOI 10.1002/(SICI)1098-1136(199601)16:1<81::AID-GLIA9>3.0.CO
[9]
2-E
[10]
Bulte JWM, 2000, AM J NEURORADIOL, V21, P1767